Adjuvant chemoradiotherapy with carboplatin and a fluoropyrimidine for resectable gastric and gastroesophageal junction cancer: A retrospective review of the Stanford experience

被引：0
|
作者：
de Bruin, M. A.
Kunz, P. L.
Sharma, V. B.
Norton, J. A.
Bastidas, J.
Chang, D. T.
Koong, A. C.
Koong, A. C.
Balise, R. R.
Ford, J. M.
Fisher, G. A.
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
[2] Valley Med Oncol Consultants, Fremont, CA USA
[3] El Camino Hosp, Los Gatos, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15674
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Carboplatin and fluoropyrimidine-based treatment for metastatic gastric and gastroesophageal junction cancer: A retrospective review of the Stanford experience
    Kunz, P. L.
    de Bruin, M. A.
    Balise, R. R.
    Fisher, G. A.
    Ford, J. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Adjuvant chemoradiotherapy in patients (pts) with resectable gastric (GC) or gastroesophageal junction cancer (GEJC): A monoinstitutional experience
    Soini, Barbara
    Pani, Giuseppe
    Caffo, Orazio
    Frisinghelli, Michela
    Veccia, Antonello
    Brugnara, Sonia
    Caldara, Alessia
    DiPasquale, MariaChiara
    Ferro, Antonella
    Mussari, Salvatore
    Murgia, Viviana
    Russo, Lucianna
    Valduga, Francesco
    Tumulo, Salvatore
    Galligioni, Enzo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Neoadjuvant Chemoradiotherapy Versus Surgery in Gastric and Gastroesophageal Junction Cancer: A Single Institutional Review
    Baltrusaitis, D.
    Cheng, H.
    Rajeev, R.
    Gamblin, T.
    Turaga, K.
    Johnston, F.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S172 - S173
  • [4] Adjuvant chemoradiotherapy versus chemotherapy for resectable gastric cancer: A systematic review and meta-analysis.
    Soon, Yu Yang
    Leong, Cheng Nang
    Tey, Jeremy Chee Seong
    Tham, Ivan Weng Keong
    Lu, Jiade Jay
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Adjuvant chemoradiotherapy in gastric cancer and carcinoma of the oesophago-gastric junction
    Stahl, M
    [J]. ONKOLOGIE, 2004, 27 (01): : 33 - 36
  • [6] Is Adjuvant Chemoradiotherapy Better than Perioperative Chemotherapy for Resectable Gastric Cancer?
    Selleck, M. J.
    Jabo, B.
    Morgan, J. W.
    Garberoglio, C. A.
    Reeves, M. E.
    Namm, J. P.
    Solomon, N. L.
    Lum, S. S.
    Senthil, M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S177 - S177
  • [7] Optimal cycles of fluoropyrimidine-based adjuvant chemotherapy for patients with resectable gastric cancer.
    Liu, Yunpeng
    Qu, Xiujuan
    Qu, Jinglei
    Zhang, Jingdong
    Liu, Jing
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Adjuvant chemoradiotherapy for gastric cancer: Review and validation study
    Varga, B.
    Lovey, J.
    Major, T.
    Nagy, T.
    Orosz, Z.
    Sulyok, Z.
    Fodor, J.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 31 - 32
  • [9] ADJUVANT CHEMORADIOTHERAPY FOR GASTRIC CANCER: REVIEW AND VALIDATION STUDY
    Varga, B.
    Lovey, J.
    Major, T.
    Nagy, T.
    Orosz, Z.
    Sulyok, Z.
    Fodor, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S221 - S221
  • [10] Safety and Feasibility of Carboplatin and Paclitaxel followed by Fluoropyrimidine Analogs and Radiation as Adjuvant Therapy for Gastric Cancer
    Mobayed, Mohammad
    Heilbrun, Lance K.
    Shields, Anthony F.
    Washington, Tara
    Venkatramanamoorthy, Raghu
    Philip, A. Philip
    El-Rayes, Bassel F.
    [J]. CASE REPORTS IN ONCOLOGY, 2009, 2 (03): : 220 - 228
12345